The review emphasizes the switching mechanisms of organic neuromorphic materials. In addition to these switching mechanisms, the capabilities of organic neuromorphic materials in tunable, conformable, ...

FREDERICK, MD, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical ...

Biological electronic device. Image by Tim Sandle. Biological electronic device. Image by Tim Sandle. A flexible, adaptable, storable patch, combining bacteria and sensors, to interface with the body ...

BioElectronics has withdrawn its second attempt in the past year to become a fully reporting public company, this time because it is being investigated by the Maryland Securities Division. The ...

The first time Northwestern Engineering’s Jonathan Rivnay appeared as co-author on a published paper – a 2006 piece in the Journal of Applied Physics – bioengineering was not on his mind. That paper, ...

Biosensors & Bioelectronics is the principal international journal devoted to research, design, development and application of biosensors and bioelectronics. It is an interdisciplinary journal serving ...

The intricacies of excitable tissues, including cardiac, nervous, and skeletal muscle systems, pose substantial challenges in creating artificial analogs that can replicate their bioelectrical, ...

FREDERICK, Md., Feb. 28, 2013 /PRNewswire/ -- BioElectronics Corporation , the maker of consumer medical devices for pain and healing, announces the initiation of a series of new clinical trials.

In this interview, AZoM speaks to Professor Jun Chen about his latest research into bioelectronics, and how he has managed to develop a human-powered bioelectronic that converts human movement into ...

FREDERICK, Md., Feb. 14, 2013 /PRNewswire/ -- BioElectronics Corporation , the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that ...

Verily (a Google company) and GlaxoSmithKline (GSK) are to spend around $712 million over the next seven years on a new venture called Galvani Bioelectronics. The new company will be based in the U.K.